MidFirst Bank’s West Pharmaceutical WST Stock Holding History

MidFirst Bank’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$799K	Hold	2,226	–	–	0.06%	182
2026 Q1	$558K	Buy	2,226 +1	+0%	+$249	0.05%	200
2025 Q4	$612K	Buy	+2,225	New	+$609K	0.05%	194

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MidFirst Bank's WST Position: Q2 2026 in Review

MidFirst Bank held its West Pharmaceutical (WST) position steady in Q2 2026 at 2,226 shares worth $799K. The position accounts for 0.06% of the portfolio, ranked #182.

MidFirst Bank first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 659 funds tracked by Wall St. Rank hold WST as of Q2 2026.

MidFirst Bank held 2,226 shares of West Pharmaceutical worth $799K as of Q2 2026.
MidFirst Bank left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.06% of MidFirst Bank's portfolio in Q2 2026, its #182 holding.
MidFirst Bank first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
659 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.